Log in
Enquire now
‌

US Patent 9987223 Compositions and methods for treating pterygium

Patent 9987223 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on June, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
Date Filed
March 30, 2017
Date of Patent
June 5, 2018
Patent Applicant
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
Patent Application Number
15474620
Patent Citations Received
‌
US Patent 11911379 Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
0
‌
US Patent 11666533 Emulsion formulations of multikinase inhibitors
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9987223
Patent Primary Examiner
‌
Theodore R West

Find more entities like US Patent 9987223 Compositions and methods for treating pterygium

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.